Form 4 for CYTK CYTOKINETICS INC
Accepted 2022-09-02 00:00:00 ET · period of report 2022-09-02 · accession 0001127602-22-022049 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-09-02 | 2022-09-02 | CYTK | SMITH SANDFORD D | Dir | S - Sale+OE | $53.97 | -11.4K | 12.2K | -48% | -$613.6K |
| DM | 2022-09-02 | 2022-09-02 | CYTK | SMITH SANDFORD D | Dir | M - OptEx | $23.66 | +11.4K | 15.2K | +296% | +$269.0K |
| DM | 2022-09-02 | 2022-09-02 | CYTK | SMITH SANDFORD D | Dir | M - OptEx | $0.00 | -11.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-02 | S | D | 11,369 | $53.97 | 12,170 | D | — | — | |
| 2 | Common | Common Stock | 2022-09-02 | M | A | 2,500 | $37.89 | 23,539 | D | — | — | |
| 3 | Common | Common Stock | 2022-09-02 | M | A | 5,834 | $24.32 | 21,039 | D | — | — | |
| 4 | Common | Common Stock | 2022-09-02 | M | A | 3,035 | $10.68 | 15,205 | D | — | — | |
| 5 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2022-09-02 | M | D | 2,500 | $0.00 | 7,500 | D | $37.89 · 2022-06-10 to 2032-05-10 | 2,500 Common Stock | |
| 6 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2022-09-02 | M | D | 5,834 | $0.00 | 0 | D | $24.32 · 2021-06-12 to 2031-05-12 | 5,834 Common Stock | |
| 7 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2022-09-02 | M | D | 3,035 | $0.00 | 0 | D | $10.68 · 2019-06-15 to 2029-05-15 | 3,035 Common Stock |